Market News
Stay updated with the latest market trends, earnings, and economic indicators.
ICICI Bank shares in focus after lender receives Sebi’s warning letter. Here's why
ICICI Bank shares are under scrutiny after Sebi issued a warning for a custodian violation related to FPI fund repatriation. Despite this, the bank stated no material impact on its financials. Meanwhile, Motilal Oswal maintains a 'Buy' rating, citing strong growth prospects and a target price of Rs 1,750.
Top Gainers & Losers on June 4: Physicswallah, Anant Raj, Force Motors, Hitachi Energy, Voltas among top gainers
The Nifty 50 and Sensex closed 0.14% and 0.03% higher at 23,396 and 74,368, respectively. The broader market, however, outperformed the benchmark indices, with both the Nifty Midcap 100 and Nifty Smallcap 100 indices rising 0.43% and 0.52%, respectively.
Stock Market News Today Live Updates: Nifty Falls Below 23,250, Sensex Slides Over 500 Points; Rajesh Exports Hits Lower Circuit After SEBI Probe
Nifty IT fell 0.6%, while Nifty Realty declined 0.47%. Nifty Financial Services and Nifty Bank slipped 0.4% and 0.38%, respectively.
Groww, Lenskart, 9 other stocks among Motilal’s non-Nifty ideas. Check full list
Motilal Oswal has revealed its top non-Nifty stock picks. The brokerage anticipates robust earnings growth for these companies. Key names include ICICI Prudential AMC, TVS Motor, and Dixon Technologies. Delhivery shows the highest projected earnings expansion. Investors can explore these opportunities for potential gains.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty extends losses to 200 points; Lenskart in focus
Sensex Today | Stock Market LIVE Updates: The bulls may take comfort from the fact that all recent selling has seen a reversal around this 23,250 - 23,350 range. A break of that level risks further downside for the index. Same is the case with the Nifty Bank, which had another 1,000-point range trading day on Monday.
Ipca Labs In Focus As Motilal Oswal Remains Bullish After Inline Q4 Results — Check Target Price, Upside
Ipca Labs delivered a steady performance in the March quarter, with Motilal Oswal maintaining its bullish stance, citing strong growth visibility in domestic formulations and export markets.
Asian Paints shares rally 4% after Q4 results. Here’s what Nomura and Motilal Oswal are saying
Asian Paints shares rose sharply after the company reported a 69% year-on-year jump in Q4FY26 profit and stronger margins. While Nomura reiterated its Buy call with a Rs 3,600 target price, Motilal Oswal maintained a Neutral stance, citing demand uncertainties despite raising earnings estimates and growth expectations.
Sensex gains 430 points, Nifty above 23,650; IndiGo, Infosys, Asian Paints among top gainers
Indian stock markets bounced back on Monday. The Sensex and Nifty saw gains of 0.5 percent each. This recovery followed a significant drop in the previous trading session. IndiGo shares led the gains, surging over 4.5 percent after their Q4 results. Broader markets also opened positively, with midcap and smallcap indices rising.
Ashok Leyland Shares In Focus As Motilal Oswal Stays Bullish Despite Near-Term Headwinds — Check Target Price, Upside And More
Ashok Leyland delivered an in-line operational performance for Q4, with Motilal Oswal maintaining a bullish stance on the stock's long-term earnings outlook despite near-term demand uncertainties.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty trades 100 pts lower; ONGC in focus
Sensex Today | Stock Market LIVE Updates: Even as the Nifty ended lower, it managed to defend 23,900 on the downside. The key level lower down for the Nifty is 23,800 on a closing basis. On the upside, 24,088, which is Tuesday's high, followed by the 24,200 - 24,250 zone could act as a potential hurdle.
Premier Energies shares in focus as promoters sell stake worth Rs 2,289 crore. Check top buyers
Promoter family members of Premier Energies sold shares worth around Rs 2,289 crore through a block deal, while institutional investors, including Quant Mutual Fund and Nomura, picked up stakes. The development comes amid strong investor interest in renewable energy and domestic solar manufacturing, supported by robust earnings growth and aggressive capacity expansion plans.
Sun Pharma Shares In Focus As Motilal Oswal Retains Bullish Call After Q4 — Check Target Price, Upside
Sun Pharma delivered in-line revenue in Q4, whereas Ebitda/PAT came in lower than expected, dragged down by higher marketing spending and lower milestone income.